I think the show me is more than just the vaccine
Post# of 36537
Even before Covid, it was about NGIO getting listed, then delayed. It was about ALTuCELL being bought and the diabetes drug and now nothing, it was about Generex getting listed and now nothing.
They put blame on bad actors as the cause of the PPS drop, but that’s been there, done that so to speak for Generex. Management owns some of it as well in delays and whatever as take out the bad actors who supposedly sold stock, then why hasn’t it bounced back, what’s going on?
I definitely would like to hear a researcher worth their weight outside of NGIO break down the science in a positive way to show all the possibilities.
I’m hoping we see some movement on an S1 being filed soon at least to show listing for NGIO is getting traction, unless joe and team are having to deal now with the three sec responses he didn’t know about.